Viridian Therapeutics, Inc. VRDN Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Viridian Therapeutics, Inc. (VRDN) reported comprehensive income (loss), net of tax, attributable to parent of -$105.91M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Viridian Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 22.2% year-over-year, from -$86.66M to -$105.91M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 44.0% compound annual growth rate (CAGR), from -$79.56M to -$342.14M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. It provides a comprehensive view of the company's financial performance by including all recognized revenues, expenses, gains, and losses. Investors use this to assess the total impact of all financial activities on the company's net worth beyond standard operating results.